Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
249 Leser
Artikel bewerten:
(0)

Medtronic plc: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region

Medtronic plc

DUBLIN and SHANGHAI - January 30, 2018 - Medtronic plc (NYSE:MDT) today announced that Alex Gu, previously Vice President, Regional Growth Initiatives, Greater China, and leader of Medtronic's Minimally Invasive Therapies Group (MITG) in Greater China, has been named Senior Vice President and President of Medtronic's Greater China Region. Medtronic's Greater China Region includes mainland China, Hong Kong SAR, and the Taiwan region. Gu will serve on the company's Executive Committee and succeeds Chris Lee, who was named President of Medtronic's Asia Pacific (APAC) Region in December. This change is effective immediately.

"Alex is a proven leader with a strong track record of driving business results in the region," said Omar Ishrak, Medtronic Chairman and CEO. "Greater China is one the most important healthcare markets in the world, and I am confident in Alex's ability to help us continue to deliver strong growth in the region. Alex is uniquely qualified to lead our Greater China team, given his current position leading the MITG business in China, as well as his past leadership experiences in the region with GE and McKinsey. I look forward to working with him in his new role."

Gu joined Medtronic as Vice President, MITG, Greater China upon the close of the Covidien acquisition in 2015. In this role, he was responsible for the commercial growth of the MITG business in the region, with MITG posting double digit growth in China under his leadership.

Most recently, Gu took on additional responsibilities for regional growth initiatives, leading the business development, medical and clinical affairs, emerging markets/private hospitals, and R&D functions in Greater China.

Gu brings nearly 20 years' experience in the China healthcare market. Prior to joining Covidien, he held roles at McKinsey & Company, General Electric, and Sabic in China and in the U.S. He also served as one of AdvaMed China Council's founding steering committee members and currently chairs the payment working group.

Gu is a native of China. He holds a bachelor's degree and master's degree in electrical engineering from Mississippi State University. He received his MBA from the University of Chicago's Booth School of Business.

About Medtronic
Medtronic plc (www.medtronic.com (http://www.medtronic.com/)), headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 84,000 people worldwide, serving physicians, hospitals and patients in approximately 160 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

-end-

Contacts:
Fernando Vivanco
Public Relations
+1-763-505-3780

Ryan Weispfenning
Investor Relations
+1-763-505-4626





This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Medtronic plc via Globenewswire

Großer Dividenden-Report 2024 von Dr. Dennis Riedl
Der kostenlose Dividenden-Report zeigt ganz genau, wo Sie in diesem Jahr zuschlagen können. Das sind die Favoriten von Börsenprofi Dr. Dennis Riedl
Jetzt hier klicken
© 2018 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.